Publication:
Persistent de Quervain tenosynovitis induced by somatotropin treatment

Placeholder

Organizational Units

Program

Authors

Yurdakul, OZAN VOLKAN
Ayture, Ltfiye
YALCINKAYA, Ebru Yilmaz

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Background: Growth hormone deficiency is a well-known clinical entity that is usually treated with somatotropin (growth hormone). Growth hormone has some frequent side effects such as intracranial hypertension, lymphedema and diabetes mellitus.

Description

Source:

Keywords:

Keywords

Citation

Yurdakul O. V. , Ayture L., YALCINKAYA E. Y. , -Persistent de Quervain tenosynovitis induced by somatotropin treatment-, JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.30, ss.1223-1226, 2017

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals

Thumbnail Image
Goal